Skip to content

Clinical trials

Terminated Lung Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Terminated Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20121
20141
20151
20161
20173
20181
20213
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Amgen1
BeOne Medicines1
Broncus Medical Inc1
Chinese Society of Lung Cancer1
Ethicon, Inc.1
Grit Biotechnology1
Guangdong Association of Clinical Trials1
Hong Kong Baptist University1
Jiangsu HengRui Medicine Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms17
Carcinoma, Non-Small-Cell Lung6
Anemia1
Bronchial Neoplasms1
Carcinoma, Bronchogenic1
Lung Diseases1
Neoplasms1
Neoplasms by Site1
Pleural Effusion1
Pleural Effusion, Malignant1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.